The Association of Periprocedural Hypertension and Adverse Outcomes in Patients Undergoing Catheter-Directed Thrombolysis

Keyphrases

• Adverse Outcomes 100%
• Hemorrhagic Complications 100%
• Peri-procedural 100%
• Catheter-directed Thrombolysis 100%
• Hypertension Outcomes 100%
• Peripheral Vascular Disease 75%
• Thrombolysis 75%
• Hypertensive 50%
• Congestive Heart Failure 50%
• Hemorrhagic Disease 50%
• Catheter-directed 50%
• Recombinant Tissue Plasminogen Activator (rt-PA) 50%
• Technical Success 50%
• High Incidence 25%
• Hypertension 25%
• Overall Mortality 25%
• Demographic Variables 25%
• End-stage Renal Disease 25%
• Patients at Risk 25%
• Advanced Age 25%
• Significant Risk Factors 25%
• Complication Rate 25%
• Retrospective Analysis 25%
• Patients with Diabetes Mellitus 25%
• Clinical Variables 25%
• Fibrinogen 25%
• Systolic Blood Pressure 25%
• P160 25%
• Blood Pressure Level 25%
• Thrombolytic Agents 25%
• Thrombolytic Therapy 25%
• Serum Fibrinogen 25%
• Catheter-related 25%
• Access Site 25%
• Hematoma 25%

Medicine and Dentistry

• Adverse Outcome 100%
• Blood Clot Lysis 100%
• Peripheral Vascular Disease 75%
• Alteplase 50%
• Thrombolytic Drug 50%
• Blood Pressure 25%
• Diabetes Mellitus 25%
• End Stage Renal Disease 25%
• Hematoma 25%
• Fibrinogen 25%
• Patient with Diabetes 25%
• Fibrinolytic Therapy 25%
• Systolic Blood Pressure 25%
• Congestive Heart Failure 25%
• Patient with Congestive Heart Failure 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Outcome 100%
• Fibrinolytic Agent 100%
• Peripheral Vascular Disease 100%
• Congestive Heart Failure 66%
• Alteplase 66%
• Diabetes Mellitus 33%
• End Stage Renal Disease 33%
• Fibrinogen 33%
• Hematoma 33%